featured
Assessing the Risk for Gout With SGLT2 Inhibitors in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study
Ann. Intern. Med 2020 Jan 14;[EPub Ahead of Print], M Fralick, SK Chen, E Patorno, SC KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.